icon-folder.gif   Conference Reports for NATAP  
 
  IDSA
ID Week 2026
October 21-24
Washington, DC

Back grey_arrow_rt.gif
 
 
 
Virologic Outcomes of Individuals Prescribed Dolutegravir/Lamivudine After an Oral Antiretroviral Therapy Treatment Interruption: Findings from the OPERA Cohort
 

 
 
  IDSA 2026 October 21-24 Wash DC
 

1022261opy

1022262opy

1022263copy

1022264copy

1022265copy

1022266copy

1022267opy

1022268opy